| Primary |
| Atrial Fibrillation |
49.1% |
| Hypertension |
11.0% |
| Cardiac Disorder |
6.0% |
| Arrhythmia |
5.4% |
| Blood Cholesterol Increased |
3.1% |
| Anticoagulant Therapy |
2.9% |
| Ill-defined Disorder |
2.7% |
| Heart Rate Irregular |
2.4% |
| Atrial Flutter |
2.3% |
| Diabetes Mellitus |
2.3% |
| Asthma |
2.2% |
| Pain |
1.5% |
| Blood Pressure Abnormal |
1.3% |
| Heart Rate Increased |
1.3% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Hypersensitivity |
1.2% |
| Anxiety |
1.0% |
| Arthritis |
1.0% |
| Cardiac Failure Congestive |
0.9% |
| Depression |
0.9% |
|
| Drug Ineffective |
13.1% |
| Death |
10.5% |
| Atrial Fibrillation |
9.4% |
| Electrocardiogram Qt Prolonged |
8.6% |
| Urinary Tract Infection |
6.4% |
| Headache |
4.4% |
| Torsade De Pointes |
4.1% |
| Unevaluable Event |
3.9% |
| Heart Rate Increased |
3.8% |
| Weight Increased |
3.8% |
| Malaise |
3.7% |
| Drug Interaction |
3.6% |
| Pneumonia |
3.4% |
| Dizziness |
3.3% |
| Ventricular Tachycardia |
3.2% |
| Vision Blurred |
3.2% |
| Weight Decreased |
3.2% |
| Nasopharyngitis |
3.0% |
| Arrhythmia |
2.7% |
| Nausea |
2.7% |
|
| Secondary |
| Atrial Fibrillation |
33.9% |
| Hypertension |
11.2% |
| Product Used For Unknown Indication |
8.5% |
| Arrhythmia |
6.2% |
| Anticoagulant Therapy |
4.9% |
| Cardiac Disorder |
4.8% |
| Asthma |
3.7% |
| Atrial Flutter |
3.4% |
| Heart Rate Increased |
3.2% |
| Heart Rate Irregular |
3.1% |
| Blood Cholesterol Increased |
2.5% |
| Drug Use For Unknown Indication |
2.0% |
| Rheumatoid Arthritis |
1.9% |
| Hypersensitivity |
1.9% |
| Arthritis |
1.8% |
| Depression |
1.6% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Tachycardia |
1.4% |
| Dyspnoea |
1.3% |
| Ventricular Tachycardia |
1.3% |
|
| Electrocardiogram Qt Prolonged |
10.6% |
| Drug Ineffective |
9.4% |
| Atrial Fibrillation |
7.1% |
| Cardiac Disorder |
7.1% |
| Urinary Tract Infection |
7.1% |
| Weight Decreased |
5.9% |
| Dyspnoea |
5.3% |
| Fatigue |
4.7% |
| Weight Increased |
4.7% |
| Drug Interaction |
4.1% |
| Heart Rate Irregular |
4.1% |
| Hypersensitivity |
4.1% |
| Palpitations |
4.1% |
| Nasopharyngitis |
3.5% |
| Ventricular Tachycardia |
3.5% |
| Headache |
2.9% |
| Malaise |
2.9% |
| Pain In Extremity |
2.9% |
| Protein Urine Present |
2.9% |
| Subdural Haematoma |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.4% |
| Atrial Fibrillation |
21.5% |
| Drug Use For Unknown Indication |
9.0% |
| Hypertension |
8.7% |
| Blood Cholesterol Increased |
4.3% |
| Cardiac Disorder |
3.6% |
| Hypothyroidism |
3.4% |
| Prophylaxis |
3.1% |
| Cardiac Failure Congestive |
2.5% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Pulmonary Arterial Hypertension |
2.1% |
| Anticoagulant Therapy |
2.1% |
| Diabetes Mellitus |
2.1% |
| Type 2 Diabetes Mellitus |
2.1% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Arrhythmia |
1.7% |
| Asthma |
1.6% |
| Insomnia |
1.6% |
| Supplementation Therapy |
1.6% |
| Heart Rate Irregular |
1.5% |
|
| Atrial Fibrillation |
10.8% |
| Vomiting |
10.8% |
| Weight Decreased |
8.6% |
| Drug Ineffective |
5.8% |
| Flushing |
5.8% |
| Respiratory Failure |
5.0% |
| Vision Blurred |
5.0% |
| Weight Increased |
5.0% |
| Death |
4.3% |
| Fatigue |
4.3% |
| Renal Failure |
4.3% |
| Abdominal Discomfort |
3.6% |
| Diarrhoea |
3.6% |
| Dizziness |
3.6% |
| Gastrointestinal Haemorrhage |
3.6% |
| Pain In Extremity |
3.6% |
| Pneumonia |
3.6% |
| Anaemia |
2.9% |
| Asthenia |
2.9% |
| Blood Pressure Increased |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
26.4% |
| Atrial Fibrillation |
20.9% |
| Heart Rate Irregular |
5.5% |
| Back Pain |
4.4% |
| Muscle Spasms |
4.4% |
| Pneumonitis |
4.4% |
| Prophylaxis |
4.4% |
| Cardiac Fibrillation |
3.3% |
| Alopecia |
2.2% |
| Back Disorder |
2.2% |
| Bone Density Decreased |
2.2% |
| Cardiac Disorder |
2.2% |
| Drug Use For Unknown Indication |
2.2% |
| Fibromyalgia |
2.2% |
| Hypertension |
2.2% |
| Infection |
2.2% |
| Nail Disorder |
2.2% |
| Nerve Compression |
2.2% |
| Supraventricular Tachycardia |
2.2% |
| Type 2 Diabetes Mellitus |
2.2% |
|
| Drug Interaction |
35.1% |
| Weight Decreased |
10.8% |
| Torsade De Pointes |
8.1% |
| Panic Disorder |
5.4% |
| Vision Blurred |
5.4% |
| Cardiac Disorder |
2.7% |
| Diarrhoea |
2.7% |
| Electrocardiogram Qt Prolonged |
2.7% |
| International Normalised Ratio Abnormal |
2.7% |
| Labelled Drug-drug Interaction Medication Error |
2.7% |
| Long Qt Syndrome |
2.7% |
| Nasal Disorder |
2.7% |
| Nervousness |
2.7% |
| Shock |
2.7% |
| Supraventricular Tachycardia |
2.7% |
| Tremor |
2.7% |
| Ventricular Extrasystoles |
2.7% |
| Visual Impairment |
2.7% |
|
